胸膜上皮瘤的不断变化的治疗环境:从机制到治疗
Yehao Yang1, Ying Yu1, Yun Fan1
1Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
Biochimica et biophysica acta. Reviews on cancer
|June 28, 2024
概括
胸膜上皮瘤 (TET) 的新疗法正在出现,包括向疗法和免疫疗法. 组合策略和新型药物显示出改善先进或复发性TET的结果的希望.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
- 免疫治疗是一种免疫疗法.
背景情况:
- 胸膜上皮瘤 (TETs) 是一种罕见的前端中瘤.
- 目前对晚期或复发性TET的治疗方法有限,主要依赖基化疗.
- 针对性疗法和免疫疗法的重大进展正在重塑TET治疗范式.
研究的目的:
- 审查抗血管原剂和免疫检查点抑制剂 (ICI) 在治疗TETs方面的进展.
- 突出结合疗法对TETs的发展和重要性.
- 探索新的治疗策略,包括抗体-药物联合体和免疫调节剂.
主要方法:
- 巩固最近在抗血管性疗法和ICI方面的进展.
- 讨论新的第一线治疗策略.
- 将分子特征和免疫型与临床数据的整合.
主要成果:
- 用抗血管原剂和ICI单一治疗显示出一些疗效.
- 组合策略对于改善患者的治疗结果至关重要.
- 新型药物和分子/免疫分析提供了新的治疗途径.
结论:
- 对TETs的治疗环境正在迅速发展,有针对性的疗法和免疫疗法.
- 了解分子和免疫机制是优化治疗疗效和安全的关键.
- 本综述提供了对TET管理的最新参考,强调了创新的方法.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
709
相关概念视频
Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
